Gefitibib
Product Intro
Gefitinib is a highly specific anti-tumor targeted therapeutic drug developed by AstraZeneca in the UK. It is the first molecular targeted drug for the treatment of non-small cell lung cancer. It plays a role by selectively inhibiting the signal transduction pathway of epidermal growth factor receptor tyrosine kinase (EGFR-TK).
Function
Gefitinib blocks EGFR signal transduction pathway on cell surface, hinders tumor growth, metastasis and angiogenesis, and can induce tumor cell apoptosis.
Application
1. Gefitinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor,.
2. An inhibitor of epidermal growth factor receptor lysine kinase (EGFR TK). For the treatment of non stem cell lung cancer. But the side effects are great.
Copyright © Shanghai Norky Pharmaceutical Co., Ltd. All Rights Reserved 沪ICP备20013299号 Powered by www.300.cn